EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease

Jiaming Ge, Mengyuan Li, Jingwen Yao, Jinling Guo, Xiankuan Li, Gang Li, Xiangli Han, Zheng Li, Ming Liu, Jing Zhao

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155643 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytomedicine, 2024. Verfasst von Jiaming Ge und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tia…. Hauptthemen laut MEDLINE: Catechin, Gastrointestinal Microbiome, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 284 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a recurrent chronic intestinal disorder that includes ulcerative colitis (UC) and Crohn's disease (CD). Its pathogenesis involves intricate interactions between pathogenic microorganisms, native intestinal microorganisms, and the intestinal immune system via the oral-gut axis. The strong correlation observed between oral diseases and IBD indicates the potential involvement of oral pathogenic microorganisms in IBD development. Consequently, therapeutic strategies targeting the proliferation, translocation, intestinal colonization and exacerbated intestinal inflammation of oral microorganisms within the oral-gut axis may partially alleviate IBD. Tea consumption has been identified as a contributing factor in reducing IBD, with epigallocatechin gallate (EGCG) being the primary bioactive compound used for IBD treatment. However, the precise mechanism by which EGCG mediates microbial crosstalk within the oral-gut axis remains unclear. In this review, we provide a comprehensive overview of the diverse oral microorganisms implicated in the pathogenesis of IBD and elucidate their colonization pathways and mechanisms. Subsequently, we investigated the antibacterial properties of EGCG and its potential to attenuate microbial translocation and colonization in the gut, emphasizing its role in attenuating exacerbations of IBD. We also elucidated the toxic and side effects of EGCG. Finally, we discuss current strategies for enhancing EGCG bioavailability and propose novel multi-targeted nano-delivery systems for the more efficacious management of IBD. This review elucidates the role and feasibility of EGCG-mediated modulation of the oral-gut axis microbiota in the management of IBD, contributing to a better understanding of the mechanism of action of EGCG in the treatment of IBD and the development of prospective treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinGastrointestinal MicrobiomeInflammatory Bowel DiseasesHumansAnimalsTeaMouthBiological Availability

Stichwörter der Autor:innen

BioavailabilityEpigallocatechin gallateInflammatory bowel diseaseIntestinal microorganismsOral-gut axisTargeted nano-delivery system

Substanzen

Catechinepigallocatechin gallateTea

Autor:innen und Institutionen

  • College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tianjin Key Laboratory of Intelligent TCM Diagnosis and Treatment Technol…
  • Tianjin Key Laboratory of Intelligent TCM Diagnosis and Treatment Technology and Equipment, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; College of Chinese Materia Medica, Tianjin Universit…
  • State Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, Tianjin 300072, China.
  • Department of Geriatric, Fourth Teaching Hospital of Tianjin University of TCM, Tianjin 300450, China.
  • Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, 236 Baidi Road, Nankai District, Tianjin 300192, China. Electronic address: liuming_tju@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, J., Li, M., Yao, J., Guo, J., Li, X., Li, G., Han, X., Li, Z., Liu, M., & Zhao, J. (2024). The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155643

Vancouver

Ge J, Li M, Yao J, Guo J, Li X, Li G, et al. The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155643

BibTeX
@article{Ge2024,
  author = {Ge, Jiaming and Li, Mengyuan and Yao, Jingwen and Guo, Jinling and Li, Xiankuan and Li, Gang and Han, Xiangli and Li, Zheng and Liu, Ming and Zhao, Jing},
  title = {The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155643}
}
Kostenlos starten →